Protagenic Therapeutics Inc (PTIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PTIX | AMGN | VRTX | REGN | BMY |
| Company | Protagenic Therapeutics Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 1.3800 | 269.18 | 397.48 | 883.20 | 45.09 |
| High | 1.4570 | 275.76 | 399.31 | 897.78 | 45.38 |
| Low | 1.3200 | 268.99 | 395.67 | 883.20 | 44.61 |
| Last | 1.3200 | 275.64 | 396.66 | 894.50 | 44.70 |
| Change | -0.0650 | +5.66 | -0.82 | +11.30 | -0.15 |
| % Change | -4.69% | +2.10% | -0.21% | +1.28% | -0.33% |
| Volume | 3,214 | 894,060 | 265,829 | 152,884 | 7,771,158 |
| 20-Day Average Volume | 10,241 | 2,105,104 | 917,717 | 446,321 | 13,091,554 |
| Previous Close | 1.3850 | 269.98 | 397.48 | 883.20 | 44.85 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.4942 | 269.59 | 400.13 | 914.80 | 49.05 |
| 20-Day Raw Stochastic | 25.75% | 62.57% | 21.87% | 22.04% | 3.22% |
| 20-Day Relative Strength | 47.67% | 50.90% | 42.59% | 38.29% | 28.63% |
| Weighted Alpha | -12.84 | +13.34 | +12.96 | +15.54 | -35.38 |
| Today's Opinion | 64% Buy | 24% Sell | 8% Sell | 8% Buy | 88% Sell |
| Previous Opinion | 48% Buy | 72% Sell | 8% Buy | 8% Sell | 88% Sell |
| Last Month's Opinion | 40% Buy | 24% Buy | 56% Buy | 80% Buy | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.60% since 04/22/24 | +1.22% since 04/22/24 | -0.60% since 04/22/24 | -0.64% since 04/22/24 | -9.18% since 04/22/24 |
| Low | 1.3000 on 04/25/24 | 265.72 on 04/26/24 | 393.00 on 04/25/24 | 875.22 on 04/26/24 | 44.34 on 04/26/24 |
| High | 1.8000 on 04/23/24 | 275.32 on 04/29/24 | 406.86 on 04/23/24 | 915.70 on 04/24/24 | 49.47 on 04/23/24 |
| 1-Month | |||||
| %Chg | -24.57% since 03/28/24 | -3.20% since 03/28/24 | -4.90% since 03/28/24 | -7.08% since 03/28/24 | -17.70% since 03/28/24 |
| Low | 1.1535 on 04/17/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 44.34 on 04/26/24 |
| High | 1.8000 on 04/23/24 | 283.91 on 04/02/24 | 421.45 on 04/01/24 | 970.20 on 04/01/24 | 54.23 on 04/01/24 |
| 3-Month | |||||
| %Chg | +73.68% since 01/29/24 | -12.20% since 01/29/24 | -8.78% since 01/29/24 | -6.42% since 01/29/24 | -10.51% since 01/29/24 |
| Low | 0.7700 on 01/30/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 44.34 on 04/26/24 |
| High | 1.8700 on 03/27/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | +67.09% since 10/27/23 | +5.22% since 10/27/23 | +11.89% since 10/27/23 | +15.38% since 10/27/23 | -12.52% since 10/27/23 |
| Low | 0.6797 on 12/04/23 | 249.70 on 10/31/23 | 341.90 on 11/16/23 | 772.84 on 10/31/23 | 44.34 on 04/26/24 |
| High | 1.8700 on 03/27/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 6,143 | 144,810,784 | 102,732,288 | 96,941,800 | 90,900,144 |
| Shares Outstanding, K | 4,435 | 536,376 | 258,459 | 109,762 | 2,026,759 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -5,000,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 8,196,000,000 | 2,517,700,000 | 3,434,300,000 | 11,477,000,000 |
| Last Quarter Net Income | -1,680,000 | 767,000,000 | 968,800,000 | 1,159,600,000 | 1,762,000,000 |
| 60-Month Beta | 0.36 | 0.58 | 0.35 | 0.11 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.38 on 04/01/24 | 4.71 on 02/06/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 05/20/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.44 | 29.59 | 23.70 | 6.08 |